CN1840065A - Dispersible tablet for eliminating inflammation and preparation method thereof - Google Patents

Dispersible tablet for eliminating inflammation and preparation method thereof Download PDF

Info

Publication number
CN1840065A
CN1840065A CN 200610032658 CN200610032658A CN1840065A CN 1840065 A CN1840065 A CN 1840065A CN 200610032658 CN200610032658 CN 200610032658 CN 200610032658 A CN200610032658 A CN 200610032658A CN 1840065 A CN1840065 A CN 1840065A
Authority
CN
China
Prior art keywords
water
radix
time
dispersible tablet
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610032658
Other languages
Chinese (zh)
Inventor
李瑞庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200610032658 priority Critical patent/CN1840065A/en
Publication of CN1840065A publication Critical patent/CN1840065A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a dispersible tablet for treating respiratory tract inflammation, bronchitis, pneumonia, acute tonsillitis, urinary system infection and biliary tract infection. The preparing process comprises the steps of disintegrating into fines, water grilling, concentrating to clear grease, and charging right amount of auxiliary materials.

Description

Dispersible tablet for eliminating inflammation and preparation method
Affiliated technical field:
The invention belongs to pharmaceutical, it mainly is to be used for respiratory tract infection, bronchitis, pneumonia, acute tonsillitis, also can be used for urinary system infection, biliary tract infection.Be a kind of dispersible tablet for eliminating inflammation and preparation method specifically.
Background technology:
At present, also do not find to have similar products and preparation method thereof on the market.
Summary of the invention:
The technical solution used in the present invention is: dispersible tablet for eliminating inflammation of the present invention and preparation method is characterized in that: quantitatively Radix Scutellariae, that Mentholum is ground into fine powder is standby; Radix Scrophulariae, Radix Gentianae, Gypsum Fibrosum, Radix Bupleuri, Fructus Gardeniae, the Rhizoma Anemarrhenae, Radix Scutellariae, more than seven flavors, decocting boils that to be concentrated into clear paste standby; Then with above-mentioned standby material, make dispersible tablet and finish a whole set of manufacture method by national standard prescription the requirements adding appropriate amount of auxiliary materials that feeds intake.This medicine is dosage form technological innovation on existing capsular basis, and agent changes into takes more conveniently, and the dispersible tablet that onset is more fast is benefited the common people.This medicine expelling pathogen from the exterior and clearing up internal heat, heat-clearing and toxic substances removing.Be used for respiratory tract infection, bronchitis, pneumonia, acute tonsillitis.Also can be used for urinary system infection, biliary tract infection.Dispersible tablet is met water disintegrate fast, and is more easy for patients to accept and be ready to take, and carry, easy to use, be clinical welcome and safe, stable, effective medicine, be the ideal product of modern pharmaceutical enterprise.
Formula constituent of the present invention is: the hot clear extractum 161g simple making method of Radix Scutellariae 137g Mentholum 2g is ground into fine powder for Radix Scutellariae drying under reduced pressure in the side; Hot clear extractum prescription and method for making are: Radix Scrophulariae 308.73g Radix Gentianae 205.20g Gypsum Fibrosum 617.46g Radix Bupleuri 205.20g Fructus Gardeniae 205.20g Rhizoma Anemarrhenae 205.20g Radix Scutellariae 147.79g, more than seven flavors, decoct with water secondary, each 1.5 hours, collecting decoction filtered, filtrate decompression is concentrated into thick paste, adds Radix Scutellariae powder, mixing, drying under reduced pressure is ground into fine powder, adds Mentholum and appropriate amount of auxiliary materials, mixing, full powder compaction dispersible tablet is made 1000, promptly.
The preparation method characteristic of the hot Yiqing dispersing tablets of the present invention is that it may further comprise the steps:
(1) in the technology in the preparation of hot clear extractum, Radix Scrophulariae, Radix Gentianae, Gypsum Fibrosum, Radix Bupleuri, Fructus Gardeniae, the Rhizoma Anemarrhenae, radix scutellariae medicinal materials are ground into coarse powder and are generally 5-30 purpose coarse powder or are cut into decoction pieces, are preferably 10 order coarse powder or are cut into decoction pieces.
(2) decocting of (2) hot clear extractum boils condition: decoct with water 2-3 time, amount of water is 6-12 times of dose for the first time, is for the second time 4-10 times of dose, and the time is each 1-2 hour.The best is: decoct with water 2 times, amount of water is 8 times of dose for the first time, is for the second time 6 times of dose, and the time is each 1.5 hours.
(3) hot clear extractum method for concentration is in the technology: heating in water bath concentrates or concentrating under reduced pressure.
(4) the spissated temperature of heating in water bath is 50-100 ℃ in the technology, and the best is: 60-80 ℃.
(5) temperature of water-bath concentrating under reduced pressure is 50-80 ℃ in the technology, and the best is: 60-75 ℃.
(6) added adjuvant is in the following adjuvant one or more in the technology: microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, carboxymethyl starch sodium, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, Pulvis Talci, starch, magnesium stearate etc.
(7) added supplementary product consumption is in the technology: 5-50% microcrystalline Cellulose, 3-30% low-substituted hydroxypropyl cellulose, 3-30% carboxymethyl starch sodium, 3-30% polyvinylpolypyrrolidone, 3-30% cross-linking sodium carboxymethyl cellulose, Pulvis Talci, starch, magnesium stearate etc. are an amount of.
(8) feed intake after above standby material is converted by requirements of national standard prescription, mix, direct dry powder sheeting or pelletizing press sheet promptly get hot Yiqing dispersing tablets.
The invention has the beneficial effects as follows: more easy for patients to accept and be ready to take, and carry, easy to use, be clinical welcome and safe, stable, effective medicine, be the ideal product of modern pharmaceutical enterprise.
Embodiment:
Dispersible tablet for eliminating inflammation of the present invention and preparation method is characterized in that: quantitatively Radix Scutellariae, that Mentholum is ground into fine powder is standby; Radix Scrophulariae, Radix Gentianae, Gypsum Fibrosum, Radix Bupleuri, Fructus Gardeniae, the Rhizoma Anemarrhenae, Radix Scutellariae, more than seven flavors, decocting boils that to be concentrated into clear paste standby; Then with above-mentioned standby material, make dispersible tablet and finish a whole set of manufacture method by national standard prescription the requirements adding appropriate amount of auxiliary materials that feeds intake.This medicine is dosage form technological innovation on existing capsular basis, and agent changes into takes more conveniently, and the dispersible tablet that onset is more fast is benefited the common people.This medicine expelling pathogen from the exterior and clearing up internal heat, heat-clearing and toxic substances removing.Be used for respiratory tract infection, bronchitis, pneumonia, acute tonsillitis.Also can be used for urinary system infection, biliary tract infection.Dispersible tablet is met water disintegrate fast, and is more easy for patients to accept and be ready to take, and carry, easy to use, be clinical welcome and safe, stable, effective medicine, be the ideal product of modern pharmaceutical enterprise.
Formula constituent of the present invention is: the hot clear extractum 161g simple making method of Radix Scutellariae 137g Mentholum 2g is ground into fine powder for Radix Scutellariae drying under reduced pressure in the side; Hot clear extractum prescription and method for making are: Radix Scrophulariae 308.73g Radix Gentianae 205.20g Gypsum Fibrosum 617.46g Radix Bupleuri 205.20g Fructus Gardeniae 205.20g Rhizoma Anemarrhenae 205.20g Radix Scutellariae 147.79g, more than seven flavors, decoct with water secondary, each 1.5 hours, collecting decoction filtered, filtrate decompression is concentrated into thick paste, adds Radix Scutellariae powder, mixing, drying under reduced pressure is ground into fine powder, adds Mentholum and appropriate amount of auxiliary materials, mixing, full powder compaction dispersible tablet is made 1000, promptly.
The preparation method characteristic of the hot Yiqing dispersing tablets of the present invention is that it may further comprise the steps:
1, in the skill in the preparation of hot clear extractum, Radix Scrophulariae, Radix Gentianae, Gypsum Fibrosum, Radix Bupleuri, Fructus Gardeniae, the Rhizoma Anemarrhenae, radix scutellariae medicinal materials are ground into coarse powder and are generally 5-30 purpose coarse powder or are cut into decoction pieces, are preferably 10 order coarse powder or are cut into decoction pieces.
2, the decocting of hot clear extractum boils condition: decoct with water 2-3 time, amount of water is 6-12 times of dose for the first time, is for the second time 4-10 times of dose, and the time is each 1-2 hour.The best is: decoct with water 2 times, amount of water is 8 times of dose for the first time, is for the second time 6 times of dose, and the time is each 1.5 hours.
3, hot clear extractum method for concentration is in the technology: heating in water bath concentrates or concentrating under reduced pressure.
4, the spissated temperature of heating in water bath is 50-100 ℃ in the technology, and the best is: 60-80 ℃
5, the temperature of water-bath concentrating under reduced pressure is 50-80 ℃ in the technology, and the best is: 60-75 ℃
6, added adjuvant is in the following adjuvant one or more in the technology: microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, carboxymethyl starch sodium, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, Pulvis Talci, starch, magnesium stearate etc.
7, added supplementary product consumption is in the technology: 5-50% microcrystalline Cellulose, 3-30% low-substituted hydroxypropyl cellulose, 3-30% carboxymethyl starch sodium, 3-30% polyvinylpolypyrrolidone, 3-30% cross-linking sodium carboxymethyl cellulose, Pulvis Talci, starch, magnesium stearate etc. are an amount of.
8, feed intake after above standby material is converted by requirements of national standard prescription, mix, direct dry powder sheeting or pelletizing press sheet promptly get hot Yiqing dispersing tablets.
The present invention is more easy for patients to accept and be ready to take, and carry, easy to use, be clinical welcome and safe, stable, effective medicine, be the ideal product of modern pharmaceutical enterprise.

Claims (3)

1, a kind of dispersible tablet for eliminating inflammation and preparation method, it is characterized in that: formula constituent of the present invention is: the hot clear extractum 161g of Radix Scutellariae 137g Mentholum 2g, hot clear extractum component is: Radix Scrophulariae 308.73g Radix Gentianae 205.20g Gypsum Fibrosum 617.46g Radix Bupleuri 205.20g Fructus Gardeniae 205.20g Rhizoma Anemarrhenae 205.20g Radix Scutellariae 147.79g.
2, dispersible tablet for eliminating inflammation according to claim 1 and preparation method, its manufacture method is characterised in that: above seven flavors decoct with water secondary, each 1.5 hours, collecting decoction filtered, filtrate decompression is concentrated into thick paste, adds Radix Scutellariae powder, mixing, drying under reduced pressure is ground into fine powder, adds Mentholum and appropriate amount of auxiliary materials, mixing, full powder compaction dispersible tablet is made 1000, promptly.
3, dispersible tablet for eliminating inflammation according to claim 1 and preparation method, its manufacture method is characterised in that: it may further comprise the steps: 1, in the preparation of the clear extractum of middle sweltering heat, Radix Scrophulariae, Radix Gentianae, Gypsum Fibrosum, Radix Bupleuri, Fructus Gardeniae, the Rhizoma Anemarrhenae, radix scutellariae medicinal materials are ground into coarse powder and are generally 5-30 purpose coarse powder or are cut into decoction pieces, are preferably 10 order coarse powder or are cut into decoction pieces; 2, the decocting of hot clear extractum boils condition: decoct with water 2-3 time, amount of water is 6-12 times of dose for the first time, is for the second time 4-10 times of dose, and the time is each 1-2 hour.The best is: decoct with water 2 times, amount of water is 8 times of dose for the first time, is for the second time 6 times of dose, and the time is each 1.5 hours; 3, hot clear extractum method for concentration is in the technology: heating in water bath concentrates or concentrating under reduced pressure; 4, the spissated temperature of heating in water bath is 50-100 ℃ in the technology, and the best is: 60-80 ℃; 5, the temperature of water-bath concentrating under reduced pressure is 50-80 ℃ in the technology, and the best is: 60-75 ℃; 6, added adjuvant is in the following adjuvant one or more in the technology: microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, carboxymethyl starch sodium, polyvinylpolypyrrolidone, cross-linking sodium carboxymethyl cellulose, Pulvis Talci, starch, magnesium stearate etc.; 7, added supplementary product consumption is in the technology: 5-50% microcrystalline Cellulose, 3-30% low-substituted hydroxypropyl cellulose, 3-30% carboxymethyl starch sodium, 3-30% polyvinylpolypyrrolidone, 3-30% cross-linking sodium carboxymethyl cellulose, and Pulvis Talci, starch, magnesium stearate etc. are an amount of; 8, feed intake after above standby material is converted by requirements of national standard prescription, mix, direct dry powder sheeting or pelletizing press sheet promptly get hot Yiqing dispersing tablets.
CN 200610032658 2006-01-05 2006-01-05 Dispersible tablet for eliminating inflammation and preparation method thereof Pending CN1840065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610032658 CN1840065A (en) 2006-01-05 2006-01-05 Dispersible tablet for eliminating inflammation and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610032658 CN1840065A (en) 2006-01-05 2006-01-05 Dispersible tablet for eliminating inflammation and preparation method thereof

Publications (1)

Publication Number Publication Date
CN1840065A true CN1840065A (en) 2006-10-04

Family

ID=37029368

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610032658 Pending CN1840065A (en) 2006-01-05 2006-01-05 Dispersible tablet for eliminating inflammation and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1840065A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101919960A (en) * 2010-08-30 2010-12-22 海南新中正制药有限公司 Inflammation and heat clearing tablets and preparation method thereof
CN102145110A (en) * 2011-03-24 2011-08-10 卞合香 Oral medicine composition for clinically nursing high fever caused by infantile respiratory tract infection and preparation method of oral medicine composition
CN103272030A (en) * 2013-05-31 2013-09-04 武伟 Pneumonic treatment medicine and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101919960A (en) * 2010-08-30 2010-12-22 海南新中正制药有限公司 Inflammation and heat clearing tablets and preparation method thereof
CN101919960B (en) * 2010-08-30 2012-06-27 海南新中正制药有限公司 Inflammation and heat clearing tablets and preparation method thereof
CN102145110A (en) * 2011-03-24 2011-08-10 卞合香 Oral medicine composition for clinically nursing high fever caused by infantile respiratory tract infection and preparation method of oral medicine composition
CN102145110B (en) * 2011-03-24 2012-06-13 卞合香 Oral medicine composition for clinically nursing high fever caused by infantile respiratory tract infection and preparation method of oral medicine composition
CN103272030A (en) * 2013-05-31 2013-09-04 武伟 Pneumonic treatment medicine and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101606962A (en) Sugarless south isatis root granules and preparation method thereof
CN1840065A (en) Dispersible tablet for eliminating inflammation and preparation method thereof
CN1839981A (en) Gynecological inflammation resisting dispersion tablet and its preparation method
CN100427136C (en) Medicinal composition for treating fatty liver, its preparation and use
CN115554325A (en) Application of medicine terminalia fruit, extractive or preparation thereof in preparing anti-inflammatory, analgesic or uric acid-reducing medicines
CN1698701A (en) Gout relaxing tablet and preparation method thereof
CN105963597A (en) Traditional Chinese medicine for treating oral ulcer
CN104707106A (en) Traditional Chinese medicine composition for treating fatty liver and preparation method thereof
CN1456256A (en) Compound pseudo-ginseng preparing method
CN1314434C (en) Heat-clearing and detoxic medicine and its preparation method
CN1456243A (en) Preparation of double coptis root dispersed tablets
CN115364179B (en) Traditional Chinese medicine composition for reducing blood uric acid as well as preparation method and application thereof
CN1593604A (en) Dispersible tablet for treating mammary glands hyperplasia and its preparing method
CN1709352A (en) Sanhuang dispersion tablet of rheum officinale, goldthread and radix scutellariae and its preparing method
CN103156988A (en) Dispersible tablet for clearing heat, relieving sore-throat, detoxifying and relieving pain, and preparation method for same
CN1965981A (en) Pharmaceutical composition for treating gynecological inflammation and method for preparing same
CN1456221A (en) Chathartic tablet preparing method
CN1660189A (en) Capsule of Chinese traditional medicine for clearing away heat and toxic materia and preparation method
CN108066437B (en) A Chinese medicinal composition and its preparation method
CN1456249A (en) Preparation of sweet dream tablets
CN1698703A (en) Gynecological inflammation diminishing tablet and its preparation method
CN1456297A (en) Tablet for regulating menstruation and removing spot, preparing method thereof
CN104800637A (en) Traditional Chinese medicine composition for treating hyperuricemia with joint swelling
CN1456300A (en) Preparation of Manganjieyu tablets against chronic hepatitis
CN114848742A (en) Preparation method of lung-clearing and fire-inhibiting capsule

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Ruiqing

Document name: Notice of publication of application for patent for invention

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Ruiqing

Document name: Notification before expiration of term

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Ruiqing

Document name: Notification that Application Deemed to be Withdrawn

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication